Cite
MLA Citation
G. L. Goll et al.. “Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial.” Journal of internal medicine, vol. 285, 2019, pp. 653–669. http://access.bl.uk/ark:/81055/vdc_100086238794.0x000028